{"news_desk": null, "print_page": null, "section_name": "false", "subsection_name": "false", "byline": {"original": "By AMIE TSANG", "person": [{"rank": 1, "role": "reported", "firstname": "Amie", "organization": "", "lastname": "TSANG"}]}, "abstract": "Thwarting the Quick Buck | Bigger is Better in Pharmaceuticals | Greek Preparations for Euro Exit", "type_of_material": "Blog", "word_count": "1984", "lead_paragraph": null, "pub_date": "2015-07-28T07:07:45Z", "document_type": "blogpost", "slideshow_credits": null, "headline": {"main": "Morning Agenda: Executive Strategy at Bank of America", "kicker": "News"}, "snippet": "Thwarting the Quick Buck | Bigger is Better in Pharmaceuticals | Greek Preparations for Euro Exit", "multimedia": [], "web_url": "http://news.blogs.nytimes.com/2015/07/28/morning-agenda-executive-strategy-at-bank-of-america/", "keywords": [{"rank": "1", "value": "Fink, Laurence D", "name": "persons"}, {"rank": "2", "value": "Greece", "name": "persons"}, {"rank": "3", "value": "Icahn, Carl C", "name": "persons"}, {"rank": "4", "value": "Moynihan, Brian T", "name": "persons"}, {"rank": "5", "value": "Varoufakis, Yanis", "name": "persons"}, {"rank": "1", "value": "Clinton, Hillary Rodham", "name": "glocations"}, {"rank": "2", "value": "Wall Street (Manhattan, NY)", "name": "glocations"}, {"rank": "1", "value": "AbbVie Inc", "name": "organizations"}, {"rank": "11", "value": "Hedge Funds", "name": "organizations"}, {"rank": "12", "value": "Honeywell International Inc", "name": "organizations"}, {"rank": "13", "value": "KKR & Co LP", "name": "organizations"}, {"rank": "14", "value": "MasterCard Inc", "name": "organizations"}, {"rank": "15", "value": "Merrill Lynch &amp; Co", "name": "organizations"}, {"rank": "16", "value": "Mylan Inc", "name": "organizations"}, {"rank": "17", "value": "Pfizer Inc", "name": "organizations"}, {"rank": "18", "value": "Private Equity", "name": "organizations"}, {"rank": "19", "value": "Teva Pharmaceutical Industries Ltd", "name": "organizations"}, {"rank": "20", "value": "Visas", "name": "organizations"}, {"rank": "2", "value": "Allergan Inc", "name": "organizations"}, {"rank": "21", "value": "Zurich Insurance Group Ltd.", "name": "organizations"}, {"rank": "3", "value": "Bank of America Corporation", "name": "organizations"}, {"rank": "4", "value": "BlackRock Inc", "name": "organizations"}, {"rank": "5", "value": "Carlyle Group LP", "name": "organizations"}, {"rank": "6", "value": "Countrywide Financial Corp", "name": "organizations"}, {"rank": "7", "value": "Delta Air Lines, Inc", "name": "organizations"}, {"rank": "8", "value": "Drugs (Pharmaceuticals)", "name": "organizations"}, {"rank": "9", "value": "Elster Group SE", "name": "organizations"}, {"rank": "10", "value": "Goldman Sachs Group Inc", "name": "organizations"}, {"rank": "1", "value": "Banking and Financial Institutions", "name": "subject"}, {"rank": "2", "value": "Capital Gains Tax", "name": "subject"}, {"rank": "3", "value": "China", "name": "subject"}, {"rank": "4", "value": "European Sovereign Debt Crisis (2010- )", "name": "subject"}, {"rank": "5", "value": "Initial Public Offerings", "name": "subject"}, {"rank": "6", "value": "Mergers, Acquisitions and Divestitures", "name": "subject"}, {"rank": "7", "value": "Stocks and Bonds", "name": "subject"}], "blog": [], "_id": "55b7635138f0d860ec81dce2", "source": "The New York Times"}